ONCOGNOSIS
DEAD

Serial Number

78280702

Owner

AMERSHAM PLC

Attorney

Catherine Mennenga

Filing Date

Jul 30, 2003

Add to watchlist:

No watchlists yet
View on USPTO

ONCOGNOSIS Trademark

Serial Number: 78280702 • Registration: 2906475

ONCOGNOSIS is a trademark filed by AMERSHAM PLC on July 30, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

AMERSHAM PLC (44 trademarks)

BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 03

GE HEALTHCARE LIMITED (94 trademarks)

AMERSHAM PLACE LITTLE CHALFONT
BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 99

Trademark Details

Filing Date

July 30, 2003

Registration Date

November 30, 2004

Published for Opposition

September 7, 2004

Cancellation Date

July 1, 2011

Goods & Services

Scientific apparatus and instruments used for radiology for the purpose of measuring, monitoring and surveying; computers, printers, and software programs used for the purpose of life science research and for nuclear cardiology and medical imaging, for use by laboratories, pharmacies, doctors, hospitals, and medical service providers; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely automated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus for manufacturing oligonucleotides; apparatus for microarrays; microarray slides; laboratory glassware; laboratory vials and microvials; microtitre plates; and parts and fittings for the aforesaid goods

Diagnostic agents, preparations and substances for medical purposes; Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinical, medical and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis; pre-filled vials and cartridges containing medical diagnostic reagents or saline solution; and radioisotope brachytherapy substances

Chemicals, biochemicals and reagents for use in industry, science and research, namely, nucleotides, fluorescent nucleotides, oligonucleotides, peptides, proteins, amino acids, organic molecules, markers for DNA/RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with polymerase chain reaction, PCR, process and the rolling circle amplification (RCA) process; reagents for cDNA cloning vectors, modifying and restriction enzymes; reagents for labeling, detecting sequencing and fragment analysis of nucleic acids, proteins, and custom synthesis; reagents for recombinant protein expression purification, chromatography media; electrophoresis; spectrophotometry and fluorometry; radiochemicals; scintillation assays; and high through put screening assays for drug development; and chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances; chemical test reagents, saline solution and reagent-coated paper, all for scientific and laboratory use; fissionable chemical elements; radioactive elements and isotopes for industrial, scientific, and research purposes; radioactive sources and standards for use in radiographic techniques; radioactive sources for use in non-destructive testing, purification or sterilizing techniques for use in industry, science and research; chemical preparations, kits and reagents for analysis or diagnosis used for scientific purposes, namely, cell separation and culture; nucleic acid purification; and radionuclides, gases and gas mixtures for industrial, scientific, and research purposes

Medical diagnostic services; medical imaging services; providing medical and medical product information to pharmaceutical companies and medical professionals

Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, comprised of medical needles, suture needles, implantable radiation therapy devices and implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography, CAT scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; diagnostic and test kits for clinical medical use comprised of test tubes, test plates and indicator charts for evaluating test results; vials; cannulas; needles and syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes; and parts and fittings for the aforesaid goods

Advisory services for pharmaceutical companies in the field of purification and chromatography; research and development services in the field of pharmaceutical and life sciences; research and product development for others, namely research and development of pharmaceutical, medical, and veterinary preparations, diagnostic media and agents for use in medical and diagnostic imaging; consultancy services relating to chemical and pharmaceutical research; analytical services in the fields of medicine, pharmaceuticals and biochemistry; radiolableling services, namely isotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionals

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 1, 2011 C8..
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 17, 2005 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 17, 2005 REAP
REGISTERED-PRINCIPAL REGISTER
Nov 30, 2004 R.PR
PUBLISHED FOR OPPOSITION
Sep 7, 2004 PUBO
NOTICE OF PUBLICATION
Aug 18, 2004 NPUB
PAPER RECEIVED
Jun 16, 2004 MAIL
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2004 CNSA
Sec. 1(B) CLAIM DELETED
Mar 19, 2004 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 19, 2004 CRFA
PAPER RECEIVED
Mar 19, 2004 MAIL
NON-FINAL ACTION E-MAILED
Jan 20, 2004 GNRT
ASSIGNED TO EXAMINER
Jan 13, 2004 DOCK